|
related topics |
{stock, price, share} |
{stock, price, operating} |
{customer, product, revenue} |
{property, intellectual, protect} |
{control, financial, internal} |
{provision, law, control} |
{personnel, key, retain} |
{acquisition, growth, future} |
{regulation, government, change} |
|
We expect to incur losses in the future and may not achieve or maintain profitability.
We have a limited operating history with which you can evaluate our current business model and prospects.
If we cannot meet our future capital requirements, our business will suffe
Our operating results may fluctuate, which may adversely affect our stock price.
Our revenues for a particular period are difficult to predict, and a shortfall in revenues may harm our operating results.
Product quality problems could lead to reduced revenues, gross margins, and net income.
Our proprietary rights may prove difficult to enforce.
We may be found to infringe on intellectual property rights of others.
We rely on the availability of third-party licenses.
Our operating results and future prospects could be materially harmed by uncertainties of regulation of the Healthcare market.
Failure to retain and recruit key personnel would harm our ability to meet key objectives.
Our stock price may continue to be volatile.
Failure to manage our planned growth could harm our business.
A few of our existing shareholders own a large percentage of our voting stock and will have a significant influence over matters requiring stockholder approval and could delay or prevent a change in control.
Liquidity of our common stock.
Sales of our common stock in the public market may lower our stock price and impair our ability to raise funds in future offerings.
Our Articles and Bylaws may delay or prevent a potential takeover of
Full 10-K form ▸
|
|
related documents |
1169567--4/15/2010--OXFORD_TECHNOLOGIES_INC |
749251--2/28/2008--GARTNER_INC |
26820--4/17/2006--PHOENIX_FOOTWEAR_GROUP_INC |
1052489--3/31/2006--AMERICAN_BANK_NOTE_HOLOGRAPHICS_INC |
901696--7/23/2007--MTI_TECHNOLOGY_CORP |
790071--3/27/2008--ARISTOTLE_CORP |
1083243--3/4/2009--ZAP_COM_CORP |
5768--6/9/2006--AMERICAN_SCIENCE_&_ENGINEERING_INC |
790071--3/26/2009--ARISTOTLE_CORP |
854852--3/31/2008--Emrise_CORP |
1030916--3/31/2010--OVM_INTERNATIONAL_HOLDING_CORP |
790071--3/24/2006--ARISTOTLE_CORP |
749251--2/20/2009--GARTNER_INC |
352998--3/31/2010--IGI_INC |
867840--9/26/2008--PRECISION_OPTICS_CORPORATION_INC |
885307--11/3/2010--JEWETT_CAMERON_TRADING_CO_LTD |
1005286--8/8/2008--LANDEC_CORP_\CA\ |
1005286--8/4/2009--LANDEC_CORP_\CA\ |
1047919--3/11/2009--AMBIENT_CORP_/NY |
1005286--7/27/2007--LANDEC_CORP_\CA\ |
1444403--4/14/2010--GOLD_STANDARD_MINING_CORP. |
1409565--9/25/2009--Puramed_Bioscience_Inc. |
1419260--9/2/2010--Andina_Group_Inc. |
1123695--4/14/2010--IMARX_THERAPEUTICS_INC |
1398797--9/19/2008--Point.360 |
790071--4/2/2007--ARISTOTLE_CORP |
887226--9/15/2008--PERCEPTRON_INC/MI |
887226--9/28/2007--PERCEPTRON_INC/MI |
867840--9/21/2010--PRECISION_OPTICS_CORPORATION_INC |
867840--9/28/2009--PRECISION_OPTICS_CORPORATION_INC |
|